Clover Health Investments CLOV Insider Ownership

NASDAQ CLOV

$4.83 +0.01 (+0.21%)

At close: Nov 9, 2026 · 4:00 PM EST

Insider Holdings by Owner

51.47Mn Shares

Vivek Garipalli10.45Mn20.3%

Andrew Toy9.08Mn17.6%

Peter J. Kuipers5.76Mn11.2%

Scott J. Leffler4.86Mn9.4%

Health Investments, Corp. /De Clover3.09Mn6.0%

Other insiders (18)18.24Mn35.4%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

23.27%

▼-0.506% pp QoQ

Shares Held by Insiders

123.13Mn

filed for Sep 2026

▼-2.13% QoQ

Shares Outstanding

529.15Mn

529,147,570 shares

Direct Holdings

38.30Mn

Indirect: 84.82Mn

Net Open-Market Trades

-940.61K

net sold · -$4.61Mn in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 5, 2026

Across the past 12 months, open-market trades by Clover Health Investments insiders were all sales, totaling $8.71 million (2.03Mn shares).

By number of insiders, Clover Health Investments saw 8 insiders sell on the open market over the past 12 months and none buy.
Andrew Toy (Chief Executive Officer) was CLOV's largest open-market seller in the past 12 months, with $4 million of sales (844.97K shares); the latest was on October 15, 2026.
Clover Health Investments' latest insider trade on the open market was a sale of 19.27K shares for $89,822 by Karen Soares (Chief Legal Officer) on October 20, 2026.
Outside the open market, Clover Health Investments insiders received 2.21Mn shares in stock awards, acquired 1.66Mn shares through option exercises and conversions and gave up 3.27Mn shares to cover taxes or exercise prices over the past 12 months.
According to Business Quant data, insiders at Clover Health Investments reported 122.65Mn shares in total in their latest Form 4 filings, or 23.18% of the 529.15Mn shares outstanding; that total is down 2.51% from 125.81Mn shares at the end of Q2 2026 and down 11.08% from 137.93Mn shares at the end of Q3 2025.
By type of ownership, CLOV insiders hold 30.84% of their shares directly (37.83Mn shares) and 69.16% indirectly (84.82Mn shares).
Business Quant counts 18 insiders with holdings in Clover Health Investments stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Clover Health Investments' three biggest insider holders are Vivek Garipalli (Director and 10% owner, 94.03Mn shares), Andrew Toy (Chief Executive Officer, 9.08Mn shares) and Peter J. Kuipers (Chief Financial Officer, 5.76Mn shares), based on their latest Form 4 filings.
Vivek Garipalli holds 76.67% of the combined insider position in Clover Health Investments.
Institutions held 27.56% of Clover Health Investments' outstanding shares in their Q2 2026 13F filings.
Over the past 12 months, 16 insiders reported transactions in Clover Health Investments stock in 84 Form 4 filings.
These insider figures for Clover Health Investments are based on Form 4 filings through October 20, 2026.

Form 4 Holdings

Insiders Holding CLOV

Insiders 23

Shares held 51.47Mn

Of outstanding 9.73%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Vivek Garipalli	Director, TenPercentOwner	10,447,340	10,447,340	20.3%	09 Jan, 2026
2	Andrew Toy	Chief Executive Officer	9,078,334	9,078,334	17.6%	19 Oct, 2026
3	Peter J. Kuipers	Chief Financial Officer	5,758,353	5,758,353	11.2%	02 Feb, 2026
4	Scott J. Leffler	Chief Financial Officer	4,857,303	4,857,303	9.4%	29 Jan, 2024
5	Health Investments, Corp. /De Clover	Chief Technology Officer	3,093,225	3,093,225	6.0%	02 Nov, 2023
6	Jamie L. Reynoso	Ceo, Medicare Advantage	2,770,351	2,770,351	5.4%	20 Oct, 2026
7	Joseph Richards Martin	General Counsel	2,718,857	2,718,857	5.3%	16 Jun, 2023
8	Aric R Sharp	Ceo Of Value Based Care	2,100,665	2,100,665	4.1%	13 Aug, 2024
9	Brady Patrick Priest	Ceo Of Clover Care Services	2,040,222	2,040,222	4.0%	13 May, 2026
10	Karen Soares	Chief Legal Officer	1,573,423	1,573,423	3.1%	20 Oct, 2026
11	Joseph Clay Thornton	Interim Cfo	1,244,935	1,244,935	2.4%	19 Oct, 2026
12	Conrad Wai	Ceo, Counterpart Health	1,042,072	1,042,072	2.0%	19 Oct, 2026
13	Prabhdeep Singh	Chief Growth Officer	872,821	872,821	1.7%	20 Sep, 2022
14	Demetrios L. Kouzoukas	Director	605,980	605,980	1.2%	08 Jan, 2026
15	Chelsea Clinton	Director	602,814	602,814	1.2%	08 Jan, 2025
16	Lee Shapiro	Director	598,622	598,622	1.2%	08 Jan, 2025
17	William G Jr Robinson	Director	597,987	597,987	1.2%	08 Jan, 2026
18	Anna U Loengard	Director	527,456	527,456	1.0%	08 Jan, 2026
19	Carladenise Armbrister Edwards	Director	285,432	285,432	0.6%	19 May, 2026
20	Joseph Frank Oldakowski	Vp Of Finance And Controller	275,897	275,897	0.5%	17 Sep, 2026
21	Robert G Torricelli	Director	186,897	186,897	0.4%	02 Oct, 2026
22	Thomas L Tran	Director	180,029	180,029	0.3%	08 Jan, 2026
23	Brian James Miller	Director	12,481	12,481	0.0%	02 Oct, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

389 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
19 Oct, 2026	Jamie L. Reynoso	Ceo, Medicare Advantage	Disposed S	4,066	$4.41	$17.93K	2,770,351	Direct
20 Oct, 2026	Karen Soares	Chief Legal Officer	Disposed S	19,275	$4.66	$89.82K	1,573,423	Direct
15 Oct, 2026	Conrad Wai	Ceo, Counterpart Health	Disposed S	23,627	$4.68	$110.57K	1,042,072	Direct
15 Oct, 2026	Jamie L. Reynoso	Ceo, Medicare Advantage	Disposed S	18,273	$4.68	$85.52K	2,774,417	Direct
15 Oct, 2026	Karen Soares	Chief Legal Officer	Disposed S	14,673	$4.68	$68.67K	1,592,698	Direct
15 Oct, 2026	Andrew Toy	Chief Executive Officer	Disposed S	62,176	$4.68	$290.98K	9,078,334	Direct
15 Oct, 2026	Joseph Clay Thornton	Interim Cfo	Disposed S	4,591	$4.68	$21.49K	1,244,935	Direct
07 Oct, 2026	Jamie L. Reynoso	Ceo, Medicare Advantage	Disposed S	2,006	$4.63	$9.29K	2,792,690	Direct
05 Oct, 2026	Jamie L. Reynoso	Ceo, Medicare Advantage	Disposed S	8,750	$4.42	$38.68K	2,794,696	Direct
30 Sep, 2026	Robert G Torricelli	Director	Acquired A	12,481	$0.00	$0	186,897	Direct
01 Oct, 2026	Andrew Toy	Chief Executive Officer	Disposed S	318,806	$4.19	$1.34Mn	9,140,510	Direct
30 Sep, 2026	Brian James Miller	Director	Acquired A	12,481	$0.00	$0	12,481	Direct
17 Sep, 2026	Jamie L. Reynoso	Ceo, Medicare Advantage	Disposed S	1,921	$4.56	$8.76K	2,803,446	Direct
16 Sep, 2026	Joseph Frank Oldakowski	Vp Of Finance And Controller	Disposed S	3,170	$4.64	$14.71K	275,897	Direct
15 Sep, 2026	Conrad Wai	Ceo, Counterpart Health	Disposed S	300,000	$4.72	$1.42Mn	1,170,056	Indirect
15 Sep, 2026	Karen Soares	Chief Legal Officer	Disposed S	6,846	$4.78	$32.72K	1,607,371	Direct
15 Sep, 2026	Jamie L. Reynoso	Ceo, Medicare Advantage	Disposed S	9,273	$4.78	$44.32K	2,805,367	Direct
14 Sep, 2026	Joseph Frank Oldakowski	Vp Of Finance And Controller	Disposed S	20,000	$5.16	$103.20K	279,067	Direct
17 Aug, 2026	Joseph Clay Thornton	Interim Cfo	Disposed S	17,775	$4.39	$78.03K	1,249,526	Direct
12 Aug, 2026	Karen Soares	Chief Legal Officer	Acquired A	108,695	$0.00	$0	1,614,217	Direct

Showing 1 to 20 of 389 transactions